Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/20/15 → 09/8/17 |
Funding
- Pharmaceutical Research Associates Incorporated: $8,163.00
Astrazeneca: A Phase II, Multi-Center, Single-Arm, Global Study of MED14736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Keresztes, Roger (PI)
- Kudelka, Andrzej (CoPI)
Project: Research